发明名称 CRYSTALLINE FORMS OF ERLOTINIB HCL AND FORMULATIONS THEREOF
摘要 The invention provides a novel crystalline form of Erlotinib HCl, processes for its preparation, and formulations thereof.
申请公布号 WO2009025876(A8) 申请公布日期 2010.03.04
申请号 WO2008US10089 申请日期 2008.08.25
申请人 PLUS CHEMICALS, S.A.;TEVA PHARMACEUTICALS USA, INC.;CANAVESI, AUGUSTO;VILLA, MARCO;GAVENDA, ALES;FAUSTMANN, JIRI;ARONHIME, JUDITH;BIGATTI, ETTORE;JEGOROV, ALEXANDR 发明人 CANAVESI, AUGUSTO;VILLA, MARCO;GAVENDA, ALES;FAUSTMANN, JIRI;ARONHIME, JUDITH;BIGATTI, ETTORE;JEGOROV, ALEXANDR
分类号 C07D239/94;A61K31/517;A61P35/00 主分类号 C07D239/94
代理机构 代理人
主权项
地址